Ohio University’s Innovation Strategy program has provided $50,000 in a seed grant to help a team of Ohio University faculty on a project named Ohio Drug Discovery Collaborative: Identification and Development of Novel Molecular Therapies for Human Disease.
This project will build a centralized, interdisciplinary initiative focused on drug discovery and development of potential therapeutics.
The team includes several faculty from the Interdisciplinary Program in Molecular and Cellular Biology in Chemistry & Biochemistry in the College of Arts & Sciences, with principle investigator Dr. Stephen Bergmeier, Professor and Chair; Dr. Jennifer Hines, Professor; Dr. Shiyong Wu, Professor; Dr. Hao Chen, Associate Professor, and Justin Holub, Assistant Professor. Other team members are Dr. Ronan Carroll, Assistant Professor of Biological Sciences, College of Arts and Sciences; Jeffrey Wiseman, Research Division; Douglas Goetz and Monica Burdick, Chemical and Biomolecular Engineering Department, Russ College of Engineering and Technology; Kelly McCall and Frank Schwartz, Specialty Medicine Department, Heritage College of Osteopathic Medicine; Xiao Zhuo Chen and Erin Murphy, Biomedical Sciences Department, Heritage College of Osteopathic Medicine.
About Ohio University’s Innovation Strategy
The program is designed to incentivize novel, interdisciplinary collaborations in the areas of teaching and learning, research and scholarship, creative activity, and the operational functions of the university.
In the last year, the Innovation Strategy has awarded $4.5 million to 16 teams of faculty and staff for such initiatives. In June, Ohio University’s Innovation Strategy program provided $350,000 in seed grants to help seven teams of faculty and staff advance new initiatives. The seed grants have been awarded to help teams develop ideas further and to make them competitive for larger Innovation Strategy awards, other internal funding or external funding.
“Funding from the Innovation Strategy enables Ohio University faculty and staff to develop and launch creative initiatives that address major challenges,” said Joseph Shields, vice president for research and creative activity and dean of the Graduate College. “Projects chosen for seed funding were identified in the review process as having significant promise, with the potential to benefit from investment that enables further development.”
Comments